inclusion of these recovered data in an updated meta-analysis of linoleic acid intervention trials showed non-significant trends toward increased risks of death from coronary heart disease (hazard ratio 1.33 (0.99 to 1.79); p=0.06) and cardiovascular disease (1.27 (0.98 to 1.65); p=0.07).